» Articles » PMID: 20881231

Aflatoxin: a 50-year Odyssey of Mechanistic and Translational Toxicology

Overview
Journal Toxicol Sci
Specialty Toxicology
Date 2010 Oct 1
PMID 20881231
Citations 212
Authors
Affiliations
Soon will be listed here.
Abstract

Since their discovery 50 years ago, the aflatoxins have become recognized as ubiquitous contaminants of the human food supply throughout the economically developing world. The adverse toxicological consequences of these compounds in populations are quite varied because of a wide range of exposures leading to acute effects, including rapid death, and chronic outcomes such as hepatocellular carcinoma. Furthermore, emerging studies describe a variety of general adverse health effects associated with aflatoxin, such as impaired growth in children. Aflatoxin exposures have also been demonstrated to multiplicatively increase the risk of liver cancer in people chronically infected with hepatitis B virus (HBV) illustrating the deleterious impact that even low toxin levels in the diet can pose for human health. The public health impact of aflatoxin exposure is pervasive. Aflatoxin biomarkers of internal and biologically effective doses have been integral to the establishment of the etiologic role of this toxin in human disease through better estimates of exposure, expanded knowledge of the mechanisms of disease pathogenesis, and as tools for implementing and evaluating preventive interventions.

Citing Articles

Peanuts ( L.) and Mycotoxins: Analytical Approaches, Prevalence, and Innovative Detoxification.

Melo B, Robalo J, Ramos F, Sanches Silva A Foods. 2025; 14(5).

PMID: 40077605 PMC: 11898414. DOI: 10.3390/foods14050902.


Fifty Years of Aflatoxin Research in Qidong, China: A Celebration of Team Science to Improve Public Health.

Chen J, Zhu Y, Qian G, Wang J, Lu J, Kensler T Toxins (Basel). 2025; 17(2).

PMID: 39998096 PMC: 11860843. DOI: 10.3390/toxins17020079.


Aflatoxin B-induced DNA adduct formation in murine kidney and liver.

Jaruga P, Vartanian V, Minko I, Dizdaroglu M, Lloyd R Environ Toxicol Pharmacol. 2025; 114:104647.

PMID: 39884450 PMC: 11875873. DOI: 10.1016/j.etap.2025.104647.


Species Differences in the Biotransformation of Aflatoxin B1: Primary Determinants of Relative Carcinogenic Potency in Different Animal Species.

Eaton D, Williams D, Coulombe R Toxins (Basel). 2025; 17(1).

PMID: 39852983 PMC: 11768628. DOI: 10.3390/toxins17010030.


Environmental exposures and the risk of hepatocellular carcinoma.

Rayapati D, McGlynn K, Groopman J, Kim A Hepatol Commun. 2025; 9(2.

PMID: 39813595 PMC: 11737496. DOI: 10.1097/HC9.0000000000000627.


References
1.
McGlynn K, Rosvold E, Lustbader E, Hu Y, Clapper M, Zhou T . Susceptibility to hepatocellular carcinoma is associated with genetic variation in the enzymatic detoxification of aflatoxin B1. Proc Natl Acad Sci U S A. 1995; 92(6):2384-7. PMC: 42488. DOI: 10.1073/pnas.92.6.2384. View

2.
Kensler T, Gange S, Egner P, Dolan P, Munoz A, Groopman J . Predictive value of molecular dosimetry: individual versus group effects of oltipraz on aflatoxin-albumin adducts and risk of liver cancer. Cancer Epidemiol Biomarkers Prev. 1997; 6(8):603-10. View

3.
Dashwood R, Negishi T, Hayatsu H, Breinholt V, Hendricks J, Bailey G . Chemopreventive properties of chlorophylls towards aflatoxin B1: a review of the antimutagenicity and anticarcinogenicity data in rainbow trout. Mutat Res. 1998; 399(2):245-53. DOI: 10.1016/s0027-5107(97)00259-5. View

4.
Bueding E, Dolan P, Leroy J . The antischistosomal activity of oltipraz. Res Commun Chem Pathol Pharmacol. 1982; 37(2):293-303. View

5.
Phillips T, Afriyie-Gyawu E, Williams J, Huebner H, Ankrah N, Ofori-Adjei D . Reducing human exposure to aflatoxin through the use of clay: a review. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2008; 25(2):134-45. DOI: 10.1080/02652030701567467. View